Pier Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $828K | Buy |
12,288
+6,320
| +106% | +$421K | 0.11% | 106 |
|
|
2026
Q1 | $375K | Buy |
5,968
+5,934
| +17,453% | +$413K | 0.06% | 107 |
|
|
2025
Q4 | $2.26K | Sell |
34
-68
| -67% | -$4.4K | ﹤0.01% | 123 |
|
|
2025
Q3 | $6.86K | Buy |
102
+12
| +13% | +$950 | ﹤0.01% | 124 |
|
|
2025
Q2 | $7.86K | Hold |
90
| – | – | ﹤0.01% | 111 |
|
|
2025
Q1 | $6.15K | Hold |
90
| – | – | ﹤0.01% | 112 |
|
|
2024
Q4 | $7K | Buy |
90
+36
| +67% | +$2.67K | ﹤0.01% | 113 |
|
|
2024
Q3 | $3.62K | Hold |
54
| – | – | ﹤0.01% | 131 |
|
|
2024
Q2 | $6.12K | Sell |
54
-21
| -28% | -$2.65K | ﹤0.01% | 124 |
|
|
2024
Q1 | $10.4K | Sell |
75
-6,325
| -99% | -$795K | ﹤0.01% | 116 |
|
|
2023
Q4 | $794K | Buy |
6,400
+1,728
| +37% | +$177K | 0.11% | 97 |
|
|
2023
Q3 | $436K | Buy |
4,672
+72
| +2% | +$8.12K | 0.07% | 102 |
|
|
2023
Q2 | $591K | Sell |
4,600
-698
| -13% | -$84.4K | 0.08% | 97 |
|
|
2023
Q1 | $616K | Sell |
5,298
-926
| -15% | -$104K | 0.09% | 105 |
|
|
2022
Q4 | $705K | Buy |
+6,224
| New | +$683K | 0.12% | 101 |
|
|
2020
Q2 | – | Sell |
-8,500
| Closed | -$572K | – | 112 |
|
|
2020
Q1 | $572K | Buy |
8,500
+1,308
| +18% | +$81.4K | 0.13% | 100 |
|
|
2019
Q4 | $393K | Buy |
7,192
+356
| +5% | +$16.9K | 0.06% | 104 |
|
|
2019
Q3 | $255K | Sell |
6,836
-124
| -2% | -$4.82K | 0.04% | 104 |
|
|
2019
Q2 | $261K | Sell |
6,960
-208
| -3% | -$6.54K | 0.04% | 107 |
|
|
2019
Q1 | $213K | Sell |
7,168
-6,468
| -47% | -$227K | 0.03% | 104 |
|
|
2018
Q4 | $408K | Buy |
+13,636
| New | +$433K | 0.08% | 103 |
|
|
2017
Q3 | – | Sell |
-26,880
| Closed | -$492K | – | 112 |
|
|
2017
Q2 | $492K | Buy |
26,880
+13,716
| +104% | +$253K | 0.08% | 113 |
|
|
2017
Q1 | $279K | Buy |
+13,164
| New | +$257K | 0.05% | 110 |
|
|
2016
Q2 | – | Sell |
-161,548
| Closed | -$2.74M | – | 120 |
|
|
2016
Q1 | $2.74M | Sell |
161,548
-103,420
| -39% | -$1.73M | 0.53% | 92 |
|
|
2015
Q4 | $5.42M | Sell |
264,968
-676
| -0.3% | -$14.1K | 0.94% | 70 |
|
|
2015
Q3 | $5.7M | Sell |
265,644
-153,664
| -37% | -$3.43M | 0.93% | 71 |
|
|
2015
Q2 | $8.38M | Sell |
419,308
-23,760
| -5% | -$417K | 1.21% | 8 |
|
|
2015
Q1 | $6.91M | Sell |
443,068
-308,484
| -41% | -$4.66M | 1.04% | 43 |
|
|
2014
Q4 | $10.3M | Sell |
751,552
-13,076
| -2% | -$160K | 1.53% | 6 |
|
|
2014
Q3 | $7.64M | Sell |
764,628
-17,940
| -2% | -$183K | 1.22% | 15 |
|
|
2014
Q2 | $7.76M | Buy |
+782,568
| New | +$6.93M | 1.1% | 28 |
|
|
2013
Q3 | – | Sell |
-1,697,468
| Closed | -$9.53M | – | 143 |
|
|
2013
Q2 | $9.53M | Buy |
+1,697,468
| New | +$8.13M | 1.45% | 14 |
|
Other funds holding DXCM
VCM
VPM
Pier Capital's DXCM Position: Q2 2026 in Review
Pier Capital increased its DexCom (DXCM) stake by 106% in Q2 2026, buying an estimated $421K and bringing the position to 12,288 shares worth $828K. The position accounts for 0.11% of the portfolio, ranked #106.
Pier Capital first reported a position in DXCM in Q2 2013 and has held it in 32 quarters since. The position peaked at $10.3M in Q4 2014. 779 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Pier Capital held 12,288 shares of DexCom worth $828K as of Q2 2026.
- Pier Capital bought 6,320 DexCom shares in Q2 2026, an estimated $421K.
- DexCom made up 0.11% of Pier Capital's portfolio in Q2 2026, its #106 holding.
- Pier Capital first reported a position in DexCom in Q2 2013 and has held it in 32 quarters since.
- Pier Capital's DexCom position peaked at $10.3M in Q4 2014.
- 779 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Pier Capital's 13F filing for Q2 2026, filed 5 Aug 2026.